Economic burden of healthcare-associated infections: an American perspective

References

• Institute of Medicine. To Err is Human: Building a Safer Health System. National Academy Press, DC, USA (2000).
   Google Scholar
• CDC. Public health focus: surveillance, prevention and control of nosocomial infections. MMWR Morb. Mortal. Wkly Rep.41(42), 783–787 (1992).
   PubMedGoogle Scholar
• Klevens RM, Edwards JR, Richards C Jr et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep.122, 160–166 (2007).
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. HHS Action Plan To Prevent Healthcare-Associated Infections. US Department of Health and Human Services, DC, USA (2009).
   Google Scholar
• Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990–2000. Am. J. Infect. Control30(3), 145–152 (2002).
   PubMed Web of Science ®Google Scholar
• Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am. J. Infect. Control33(9), 501–509 (2005).
   PubMed Web of Science ®Google Scholar
• Scott R II. The Direct Medical Costs of Healthcare-Associated Infections in US Hospitals and the Benefits of Prevention. Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention. Polock DA, Stone PW (Eds). Economist, London, UK (2009).
   Google Scholar
• Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg. Infect. Dis.9(2), 196–203 (2003).
   PubMed Web of Science ®Google Scholar
• Perencevich EN, Stone PW, Wright SB, Carmeli Y, Fisman DN, Cosgrove SE. Raising standards while watching the bottom line: making a business case for infection control. Infect. Control Hosp. Epidemiol.28(10), 1121–1133 (2007).
   PubMedGoogle Scholar
• NNIS. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control32(8), 470–485 (2004).
   PubMed Web of Science ®Google Scholar
• Marschall J, Agniel D, Fraser VJ, Doherty J, Warren DK. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. J. Antimicrob. Chemother.61(6), 1376–1383 (2008).
   PubMed Web of Science ®Google Scholar
• Stone PW, Gupta A, Loughrey M et al. Attributable costs and length of stay of an extended-spectrum β-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol.24(8), 601–606 (2003).
   PubMed Web of Science ®Google Scholar
• Wilson SJ, Knipe CJ, Zieger MJ et al. Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. Am. J. Infect. Control32(6), 342–344 (2004).
   PubMed Web of Science ®Google Scholar
• Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect. Control Hosp. Epidemiol.24(4), 251–256 (2003).
   PubMed Web of Science ®Google Scholar
• Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob. Agents Chemother.50(1), 43–48 (2006).
   PubMed Web of Science ®Google Scholar
• Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin. Infect. Dis.15(42 Suppl. 2), S82–S89 (2006).
   Google Scholar
• Qavi A, Segal-Maurer S, Mariano N et al. Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case–control study. Infect. Control Hosp. Epidemiol.26(1), 63–68 (2005).
   Google Scholar
• Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect. Control Hosp. Epidemiol.26(2), 166–174 (2005).
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis.36(1), 53–59 (2003).
   PubMed Web of Science ®Google Scholar
• Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med. J. Aust.175(5), 264–267 (2001).
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Jhung M. Clostridium difficile-associated disease in US hospitals, 1993–2005. AHRQ Healthcare Cost and Utilization Project Statistical Brief. J. Am. Public Health Assoc.50, 1–11 (2008).
   Google Scholar
• Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin. Infect. Dis.34(3), 346–353 (2002).
   PubMed Web of Science ®Google Scholar
• Wright D. Health and Human Services Action Plan Update. US DHHS, DC, USA (2009).
   Google Scholar
• CDC. Reduction in central line-associated bloodstream infections among patients in intensive care units – Pennsylvania, April 2001–March 2005. MMWR Morb. Mortal. Wkly Rep.54(40), 1013–1016 (2005).
   PubMedGoogle Scholar
• Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med.355(26), 2725–2732 (2006).
   PubMed Web of Science ®Google Scholar
• Pronovost PJ, Berenholtz SM, Goeschel C et al. Improving patient safety in intensive care units in Michigan. J. Crit. Care23(2), 207–221 (2008).
   PubMed Web of Science ®Google Scholar
• Horan TC, Lee TB. Surveillance: into the next millennium. Am. J. Infect. Control25(2), 73–76 (1997).
   Google Scholar
• Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am. J. Infect. Control25(2), 112–116 (1997).
   PubMed Web of Science ®Google Scholar
• Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm. Rep.53(RR 3), 1–36 (2004).
   PubMedGoogle Scholar
• Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect. Control Hosp. Epidemiol.23(12 Suppl.) S3–S40 (2002).
   PubMed Web of Science ®Google Scholar
• O’Grady NP, Alexander M, Dellinger EP et al.; Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm. Rep.51(RR 10), 1–29 (2002).
   PubMedGoogle Scholar
• Garner JS. Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee. Am. J. Infect. Control24(1), 24–31 (1996).
   PubMed Web of Science ®Google Scholar
• Wong E. Guideline for prevention of catheter-associated urinary tract infections. Am. J. Infect. Control11(1), 28–36 (1983).
   Google Scholar
• Jane D, Siegel M, Rhinehart E, Jackson MP, Chiarello LR. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Healthcare Infection Control Practices Advisory Committee, GA, USA (2007).
   Google Scholar
• Seigel J, Rhinehart E, Jackson M, Chiarello L. Management of Multidrug-Reistant Organisms in Healthcare Settings, 2006. Healthcare Infection Control Practices Advisory Committee, GA, USA (2006).
   Google Scholar
• Stone PW, Hasan S, Quiros D, Larson EL. Effect of guideline implementation on costs of hand hygiene. Nurs. Econ.25(5), 279–284 (2007).
   PubMed Web of Science ®Google Scholar
• Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect. Control Hosp. Epidemiol.21(6), 375–380 (2002).
   Google Scholar
• Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch. Intern. Med.160(17), 2670–2675 (2002).
   Google Scholar
• LeDell K, Muto CA, Jarvis WR, Farr BM. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect. Control Hosp. Epidemiol.24(9), 639–641 (2003).
   Google Scholar
• Muto CA, Jarvis WR, Farr BM. Another tale of two guidelines. Clin. Infect. Dis.43(6), 796–797 (2006).
   Google Scholar
• Muto CA, Jernigan JA, Ostrowsky BE et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect. Control Hosp. Epidemiol.24(5), 362–386 (2003).
   PubMed Web of Science ®Google Scholar
• Aboelela SW, Saiman L, Stone PW, Lowy FD, Quiros D, Larson E. Effectiveness of barrier precautions and surveillance cultures to control transmission of multi-drug resistant organisms. Am. J. Infect. Control34, 484–494 (2006).
   PubMedGoogle Scholar
• Huang SS, Yokoe DS, Hinrichsen VL et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis.43(8), 971–978 (2006).
   PubMed Web of Science ®Google Scholar
• Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am. J. Infect. Control37(2), 85–93 (2009).
   PubMed Web of Science ®Google Scholar
• Berwick DM. Public performance reports and the will for change. JAMA288(12), 1523–1524 (2002).
   Google Scholar
• Marshall MN, Shekelle PG, Leatherman S, Brook RH. The public release of performance data: what do we expect to gain? A review of the evidence. JAMA283(14), 1866–1874 (2002).
   Google Scholar
• Romano PS, Zhou H. Do well-publicized risk-adjusted outcomes reports affect hospital volume? Med. Care42(4), 367–377 (2004).
   Google Scholar
• Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC. National Healthcare Safety Network (NHSN) report, data summary for 2006 through 2007, issued November 2008. Am. J. Infect. Control36(9), 609–626 (2008).
   PubMedGoogle Scholar
• Milstein A. Ending extra payment for ‘never events’ – stronger incentives for patients’ safety. N. Engl. J. Med.360(23), 2388–2390 (2009).
   PubMedGoogle Scholar
• Rosenthal MB, Fernandopulle R, Song HR, Landon B. Paying for quality: providers’ incentives for quality improvement. Health Aff. (Millwood )23(2), 127–141 (2004).
   Web of Science ®Google Scholar
• Wright SB, Huskins WC, Dokholyan RS, Goldmann DA, Platt R. Administrative databases provide inaccurate data for surveillance of long-term central venous catheter-associated infections. Infect. Control Hosp. Epidemiol.24(12), 946–949 (2003).
   Google Scholar
• Stone P, Horan T, Huai-Che S, Mooney-Kane C, Larson EL. Comparisons of healthcare associated infections using two different mechanisms for public reporting. Am. J. Infect. Control35(3), 145–149 (2007).
   Google Scholar
• Stevenson KB, Khan Y, Dickman J et al. Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections. Am. J. Infect. Control36(3), 155–164 (2008).
   Google Scholar
• Rosenthal MB. Nonpayment for performance? Medicare’s new reimbursement rule. N. Engl. J. Med.357(16), 1573–1575 (2007).
   PubMed Web of Science ®Google Scholar
• Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA294(14), 1788–1793 (2005).
   PubMed Web of Science ®Google Scholar
• Mehrotra A, Damberg CL, Sorbero ME, Teleki SS. Pay for performance in the hospital setting: what is the state of the evidence? Am. J. Med. Qual.24(1), 19–28 (2009).
   PubMed Web of Science ®Google Scholar
• Campbell SM, Reeves D, Kontopantelis E, Sibbald B, Roland M. Effects of pay for performance on the quality of primary care in England. N. Engl. J. Med.361(4), 368–378 (2009).
   PubMed Web of Science ®Google Scholar
• Conway PH, Clancy C. Comparative–effectiveness research – implications of the federal coordinating council’s report. N. Engl. J. Med.361(4), 328–330 (2009).
   PubMed Web of Science ®Google Scholar